RTTNews | Sep 30, 2021 06:09AM EDT

06:08 Thursday, September 30, 2021 (RTTNews.com) - AIM ImmunoTech, HVIVO Sign Clinical Trial Agreement For Phase 2a Human Challenge Trial Of Ampligen

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2021 RTTNews.com All Rights Reserved